Potassium channel subfamily K member 9


  • Accession: Q9NPC2
  • Swissprot: KCNK9_HUMAN
  • Organism: Homo sapiens
  • Gene: KCNK9
  • Target classes: Ion channel, Unclassified

Drug Relations:

A fluorinated ether that is used as a volatile anesthetic for maintenance of general anesthesia. Bioactivity details MOA
A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225) Bioactivity details MOA
An extremely stable inhalation anesthetic that allows rapid adjustments of anesthesia depth with little change in pulse or respiratory rate. Bioactivity details MOA
A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) Bioactivity details MOA
A stable, non-explosive inhalation anesthetic, relatively free from significant side effects. Bioactivity details MOA
A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION. Bioactivity details MOA